|
Taro Pharmaceutical Industries manufactures drugs for cardiac, dermatological, neurological, and pediatric illnesses. It makes generic prescription and over-the-counter drugs at facilities in Canada, Ireland, Israel, the UK, and the US. It specializes in generics, but also produces private label and branded drugs. Its facilities are capable of producing topical, oral, and injectable formulations. The company also produces active pharmaceutical ingredients for use by its own facilities and sold to other drug makers. Taro Pharmaceutical routinely reinvests more than 10% of its sales into research into the development of new products. Its customers include large drugstore and grocery chains and discount retailers.
|
| | | Contact Information | |
Address: |
Euro Pk., Italy Bldg., Yakum Business Pk.
Yakum 60972, Israel
| | Phone: | +972-9-971-1821 | | Fax: | +972-9-955-7443 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 341.90 M |
|
|
Key People
| | • |
Chairman:
Barrie Levitt
| | • |
SVP and CFO, Taro Pharmaceutical Industries and Taro USA:
Ron Kolker
| | • |
VP Information Technology, Israel:
Tzvi Tal
|
|
|
